Our Company
About Us
Diverse Supplier
Our Facility
Our Process
Focus & Responsibility
Molecules
Careers
Nexus Cares
Women in STEM
Philanthropic Efforts
News
Contact Us
Resources
FAQ's
Nexus News
Nexus Pharmaceuticals LLC Announces Appointment of New Board Members
Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin
Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe
Nexus Pharmaceuticals in Top 20 Best Workplaces in Chicago
Nexus Pharmaceuticals Inc. Receives FDA Approval of Erythromycin
Our Response to “Our Drug Supply Is Sick. How Can We Fix It?”
Nexus Pharmaceuticals Receives Patent for EMERPHED®
Nexus Pharmaceuticals Celebrates Grand Opening of New Facility
Industry Partnership on EMERPHED® (Ephedrine Sulfate)
Parkside Athletics Announces Partnership with Nexus
Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP
Nexus Pharmaceuticals Receives FDA Approval for Potassium Chloride in Water for Injection
Nexus Pharmaceuticals Announces Verbal to Occupy Authorization
Nexus Pharmaceuticals Discusses COVID-19 Response in BioForward Webinar
Nexus Pharmaceuticals sets month for $100M plant opening, preps drug for treating Covid patients
Nexus Pharmaceuticals Announces Diversity Certification
Nexus Pharmaceuticals Announces Great Place to Work® Certification
Nexus Pharmaceuticals Receives FDA Approval for Succinylcholine Chloride Injection, USP
Nexus Pharmaceuticals Named One of the 2020 Best Workplaces in Chicago by Great Place to Work®
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™
Nexus Pharmaceuticals Official Response: Supply Chain Reassurance Amid COVID-19 Outbreak
Nexus Pharmaceuticals Ranks #574 in Inc. 5000 Fastest-Growing Private Companies in America
Nexus Pharmaceuticals to Build Industry-Leading Sterile Injectable Manufacturing Facility in Pleasant Prairie, Wisconsin
Nexus Pharmaceuticals Receives FDA Approval for Prochlorperazine Edisylate Injection, USP
Nexus Pharmaceuticals Announces FDA Approval of Dicyclomine HCl Injection, USP
Nexus Pharmaceuticals Announces FDA Approval of Busulfan Injection
Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial
Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection
Nexus Pharmaceuticals Receives FDA Approval for Isoproterenol Injection
Nexus Pharmaceuticals Receives FDA Approval for Sodium Nitroprusside Injection
